Thursday, 02 May 2024
United Therapeutics Corporation
01:11 | 19/3/18
StockNewsTimes
United Therapeutics logo Flinton Capital Management LLC lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR) by 62.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
more»
22:56 | 14/3/18
PR Newswire
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 14, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.
more»
02:41 | 14/3/18
Danvers Record
Analysts often provide buy/sell/hold recommendations for companies that they cover. Investors have the ability to follow these sell-side ratings in order to assist with stock analysis.
more»
01:45 | 14/3/18
Business Daily
In taking a look at some key indicators for United Therapeutics Corporation (NasdaqGS:UTHR), we note that the current Book to Market value for the firm is at 0.418782.
more»
09:15 | 9/3/18
Seeking Alpha
United Therapeutics (UTHR +5.6%) is up average volume in an attempt to break free of the persistent downtrend. Shares had lost 27% of their value this year before today's action.
more»
04:11 | 9/3/18
Jonesboro Recorder
Using projections from 9 individual sell-side analysts polled by Zacks Research, United Therapeutics Corporation (NASDAQ:UTHR) has a current quarter EPS consensus estimate of 3.64.
more»
03:35 | 9/3/18
Stocks Gallery
Shares of United Therapeutics Corporation (UTHR) moved -2.44% in the recent trading day. Last trading transaction put the stock price at $110.02.
more»
05:12 | 8/3/18
Wallstreet Investorplace
United Therapeutics Corporation (UTHR) ticked a yearly performance of -23.35% while year-to-date (YTD) performance stood at -23.78%.
more»
No Risk Alert Here: Before we dive into any analysis we simply note that United Therapeutics Corporation (NASDAQ:UTHR) risk is neither elevated nor depressed.
more»
23:52 | 7/3/18
PR Newswire
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an ...
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |